Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study

Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardizat...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 48; no. 11; pp. 1593 - 1601
Main Authors Ceriotti, Ferruccio, Henny, Joseph, Queraltó, Josep, Ziyu, Shen, Özarda, Yeşim, Chen, Baorong, Boyd, James C., Panteghini, Mauro
Format Journal Article Conference Proceeding
LanguageEnglish
Published Berlin Walter de Gruyter 01.11.2010
De Gruyter
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601.
AbstractList Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively. For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations.
Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601.
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population.BACKGROUNDAspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population.AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire.METHODSAST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire.AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively.RESULTSAST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively.For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations.CONCLUSIONSFor AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations.
Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601.
Author Henny, Joseph
Ceriotti, Ferruccio
Özarda, Yeşim
Queraltó, Josep
Ziyu, Shen
Panteghini, Mauro
Boyd, James C.
Chen, Baorong
Author_xml – sequence: 1
  givenname: Ferruccio
  surname: Ceriotti
  fullname: Ceriotti, Ferruccio
  organization: Diagnostica e Ricerca S. Raffaele, Istituto Scientifico Universitario S. Raffaele, Milano, Italy
– sequence: 2
  givenname: Joseph
  surname: Henny
  fullname: Henny, Joseph
  organization: Laboratoire de Biologie Clinique, Centre de Médicine Préventive, Vandoeuvre-lès-Nancy, France
– sequence: 3
  givenname: Josep
  surname: Queraltó
  fullname: Queraltó, Josep
  organization: Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
– sequence: 4
  givenname: Shen
  surname: Ziyu
  fullname: Ziyu, Shen
  organization: National Center for Clinical Laboratory, Beijing Hospital Compound, Beijing, P.R. China
– sequence: 5
  givenname: Yeşim
  surname: Özarda
  fullname: Özarda, Yeşim
  organization: Uludag University Medical School, Department of Biochemistry and Clinical Biochemistry, Bursa, Turkey
– sequence: 6
  givenname: Baorong
  surname: Chen
  fullname: Chen, Baorong
  organization: Beijing Aerospace General Hospital, Beijing, P.R. China
– sequence: 7
  givenname: James C.
  surname: Boyd
  fullname: Boyd, James C.
  organization: University of Virginia Health System, Department of Pathology, Charlottesville, VA, USA
– sequence: 8
  givenname: Mauro
  surname: Panteghini
  fullname: Panteghini, Mauro
  organization: Centro Interdipartimentale per la Riferibilità Metrologica in Medicina di Laboratorio (CIRME), Università degli Studi, Milano, Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23441969$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21034260$$D View this record in MEDLINE/PubMed
BookMark eNqFkctu1DAUhi3Uil5gyRZ5g6ASKXZ8y7CrAh0qTUURw9pyMifIENtT20HMa8F78Ex42ikIhMTKl_Od2_8foT0fPCD0iJJTKqh40baLy9OalCej4h46pJypijNG927uvJKypgfoKKVPhFAhuLqPDmpKGK8lOUTf2uBc8DjCABF8D9j6DPGLGRMeQsQmrU3MJgM2zvqQo_GpkCYBfnb2fnnyHJvReOv_GV8sT7DxK_zje_VxnLJxmxH_QcznhbAeJ4iTe1mGSNOYS-MYXEnEF-dti135sj1sp8IpT6vNA7Q_lPHg4e48Rh_OXy_bN9Xi7fyiPVtUPZMkl71B0KEnHZFGUNrRogNINYCpO1UDH_hMCTMQoKLZRqVUpoGuG5pGkBkYdoye3tZdx3A9Qcra2dTDWPaFMCWtJOOK0kYU8vGOnDoHK72O1pm40XcyF-DJDjCpN-NQNOht-s0xzulMzgrHbrk-hpSKJ7q3RXwbfJHNjpoSvTVdb03XW9N1Mb1kVX9l3RX-D29Thq-_YBM_a6mYEvrdkusrTq8uad3oV-wn_sS96Q
CitedBy_id crossref_primary_10_1016_j_abb_2019_108062
crossref_primary_10_1515_tjb_2015_0030
crossref_primary_10_1038_ajg_2016_517
crossref_primary_10_1016_j_eclinm_2022_101435
crossref_primary_10_1515_cclm_2012_0682
crossref_primary_10_1515_cclm_2013_0371
crossref_primary_10_1515_cclm_2019_0055
crossref_primary_10_1016_j_cca_2014_01_025
crossref_primary_10_1016_j_clinbiochem_2017_03_024
crossref_primary_10_1111_liv_15164
crossref_primary_10_2217_fmb_2017_0131
crossref_primary_10_1016_S1701_2163_16_35105_2
crossref_primary_10_1177_147323001204000225
crossref_primary_10_3390_livers1040023
crossref_primary_10_1007_s11356_022_25072_4
crossref_primary_10_1007_s11357_023_00895_2
crossref_primary_10_1515_cclm_2018_1341
crossref_primary_10_1186_s41687_023_00589_5
crossref_primary_10_11613_BM_2017_038
crossref_primary_10_1515_labmed_2016_0040
crossref_primary_10_1016_j_cca_2013_03_030
crossref_primary_10_1080_10408363_2018_1476455
crossref_primary_10_5662_wjm_v6_i1_93
crossref_primary_10_3390_metabo13070850
crossref_primary_10_1371_journal_pone_0260022
crossref_primary_10_1016_j_cca_2021_08_012
crossref_primary_10_1515_cclm_2020_0015
crossref_primary_10_3390_jcm12093174
crossref_primary_10_1002_jcph_913
crossref_primary_10_1515_labmed_2020_0131
crossref_primary_10_3390_jpm13091319
crossref_primary_10_1002_hep4_1794
crossref_primary_10_1373_clinchem_2017_274977
crossref_primary_10_1055_s_0042_1749117
crossref_primary_10_3389_fmed_2024_1431578
crossref_primary_10_34172_mejdd_2020_182
crossref_primary_10_5114_aoms_199704
crossref_primary_10_1515_cclm_2016_0035
crossref_primary_10_1111_dth_15052
crossref_primary_10_1016_j_cca_2016_09_015
crossref_primary_10_3390_nu14132688
crossref_primary_10_1016_S0992_5945_20_30234_8
crossref_primary_10_7759_cureus_32541
crossref_primary_10_1111_j_1478_3231_2011_02749_x
crossref_primary_10_1373_clinchem_2015_240515
crossref_primary_10_1016_j_mayocp_2020_07_024
crossref_primary_10_1016_j_cca_2016_10_004
crossref_primary_10_1155_2013_429037
crossref_primary_10_1016_j_cca_2021_12_026
crossref_primary_10_2478_jomb_2019_0046
crossref_primary_10_1016_j_imu_2023_101369
crossref_primary_10_1016_j_jep_2025_119371
crossref_primary_10_1093_ajcp_aqw069
crossref_primary_10_3168_jds_2015_10265
crossref_primary_10_1371_journal_pone_0072916
crossref_primary_10_1111_ijpo_12152
crossref_primary_10_1097_QAD_0000000000001278
crossref_primary_10_3389_fmed_2023_1094733
crossref_primary_10_1016_j_fsi_2022_07_034
crossref_primary_10_1097_MEG_0000000000002325
crossref_primary_10_1177_2168479017700679
crossref_primary_10_1515_cclm_2018_0152
crossref_primary_10_1002_jpn3_12460
crossref_primary_10_1111_1751_2980_12475
crossref_primary_10_1515_CCLM_2011_741
crossref_primary_10_3109_10826084_2011_620053
crossref_primary_10_1515_cclm_2016_0661
crossref_primary_10_1093_toxsci_kfae143
crossref_primary_10_1111_dme_12972
crossref_primary_10_1111_liv_15068
crossref_primary_10_1002_hed_27701
crossref_primary_10_1515_labmed_2023_0042
crossref_primary_10_1002_hep_24725
crossref_primary_10_1017_S2040174416000635
crossref_primary_10_1097_MEG_0000000000001225
crossref_primary_10_1007_s12291_024_01286_w
crossref_primary_10_1515_tjb_2017_0299
crossref_primary_10_1093_clinchem_hvac142
crossref_primary_10_1371_journal_pone_0302859
crossref_primary_10_1093_ajcp_aqy015
crossref_primary_10_1007_s00204_016_1723_x
Cites_doi 10.1515/CCLM.2010.075
10.1016/j.cca.2008.06.005
10.1016/j.cca.2005.12.033
10.1002/hep.23358
10.1016/j.cca.2009.06.021
10.1515/CCLM.2010.084
10.1111/j.1572-0241.2006.00627_6.x
10.1515/CCLM.2007.290
10.1515/CCLM.2004.121
10.1515/CCLM.2005.095
10.1309/W8J8-5AG4-WDG6-JGJ9
10.1373/clinchem.2007.098228
10.1002/hep.23200
10.1093/clinchem/48.11.1987
10.7326/0003-4819-137-1-200207020-00006
10.1080/00365510410006694
10.1046/j.1423-0410.2003.00347.x
10.3109/00365519509089619
10.1046/j.1440-1746.2002.02881.x
10.1016/S0009-8981(02)00341-8
10.1136/jcp.2007.053637
10.1016/j.ab.2007.10.025
10.1373/clinchem.2007.091843
10.1080/00365510410002742
10.1001/archinternmed.2007.131
10.1258/acb.2008.008170
10.1515/CCLM.2004.133
10.1023/A:1022809430756
10.1373/clinchem.2003.027953
ContentType Journal Article
Conference Proceeding
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
CorporateAuthor Committee on Reference Systems for Enzymes (C-RSE)
IFCC Committee on Reference Intervals and Decision Limits (C-RIDL)
CorporateAuthor_xml – name: Committee on Reference Systems for Enzymes (C-RSE)
– name: IFCC Committee on Reference Intervals and Decision Limits (C-RIDL)
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1515/CCLM.2010.315
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 1601
ExternalDocumentID 21034260
23441969
10_1515_CCLM_2010_315
ark_67375_QT4_P41PM128_D
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GroupedDBID ---
-~0
0R~
0~D
1CY
29B
354
36B
4.4
53G
5GY
5RE
9-L
AAAEU
AABBZ
AAFNC
AAFPC
AAGVJ
AAILP
AALGR
AAONY
AAOQK
AAOTM
AAOWA
AAPJK
AAQCX
AASQH
AAWFC
AAXCG
ABAOT
ABAQN
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABRQL
ABUBZ
ABUVI
ABVMU
ABWLS
ABXMZ
ABYBW
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACXLN
ACZBO
ADALX
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
ADUQZ
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFAUI
AFBAA
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AGGNV
AHOVO
AHVWV
AHXUK
AIERV
AIKXB
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
ALYBR
AMAVY
ASPBG
ASYPN
AVWKF
AZFZN
AZMOX
BAKPI
BBCWN
BCIFA
BSCLL
BWHEM
CAG
CGQUA
COF
CS3
DA2
DBYYV
DU5
EJD
EMOBN
F5P
FSTRU
HZ~
IL9
IY9
KDIRW
N9A
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
~Z8
AARRE
AAYXX
ABDRH
ACDEB
ACRPL
ACUND
ACYCL
ADNMO
AECWL
AFBDD
AFSHE
AGQPQ
AIWOI
CITATION
EBS
LVMAB
.55
.GJ
AI.
IQODW
VH1
X7M
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c360t-66e51fc0b06a511b1621e67fea2b72e4f4975af0e1581b16667a8ebbf88509ea3
ISSN 1434-6621
1437-4331
IngestDate Thu Jul 10 18:56:09 EDT 2025
Thu Apr 03 07:08:52 EDT 2025
Mon Jul 21 09:15:47 EDT 2025
Thu Apr 24 22:53:42 EDT 2025
Tue Jul 01 02:49:12 EDT 2025
Wed Oct 30 09:48:35 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Reference value
Enzyme
Transferases
Multicenter study
alanine aminotransferase
Result
aspartate aminotransferase
Medicine
Transaminases
Aspartate transaminase
Clinical biology
Alanine transaminase
γ-glutamyl transferase
Serum
reference intervals
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c360t-66e51fc0b06a511b1621e67fea2b72e4f4975af0e1581b16667a8ebbf88509ea3
Notes cclm.2010.315.pdf
ark:/67375/QT4-P41PM128-D
istex:F5BEE552B8AE7DDFC46082E4A20CDF7AE7E4D083
ArticleID:cclm.2010.315
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21034260
PQID 763471185
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_763471185
pubmed_primary_21034260
pascalfrancis_primary_23441969
crossref_citationtrail_10_1515_CCLM_2010_315
crossref_primary_10_1515_CCLM_2010_315
istex_primary_ark_67375_QT4_P41PM128_D
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-11-01
PublicationDateYYYYMMDD 2010-11-01
PublicationDate_xml – month: 11
  year: 2010
  text: 2010-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin
PublicationPlace_xml – name: Berlin
– name: Germany
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2010
Publisher Walter de Gruyter
De Gruyter
Publisher_xml – name: Walter de Gruyter
– name: De Gruyter
References p_27
Roberts WL (p_18) 2006
p_28
p_29
p_23
p_24
p_25
p_26
p_20
p_22
p_16
p_38
p_17
p_39
p_34
p_13
Prati D (p_30) 2002; 137
p_35
p_6
p_14
p_36
p_37
p_7
p_9
Ceriotti F (p_8) 2007; 28
Lahti A (p_19) 2002; 48
p_31
p_10
p_32
p_11
p_33
Ceriotti F (p_21) 2007; 31
References_xml – ident: p_6
  doi: 10.1515/CCLM.2010.075
– volume: 28
  start-page: 115
  year: 2007
  ident: p_8
  publication-title: Clin Biochem Rev
– ident: p_38
  doi: 10.1016/j.cca.2008.06.005
– ident: p_13
  doi: 10.1016/j.cca.2005.12.033
– ident: p_24
  doi: 10.1002/hep.23358
– ident: p_36
  doi: 10.1016/j.cca.2009.06.021
– ident: p_26
  doi: 10.1515/CCLM.2010.084
– ident: p_35
  doi: 10.1111/j.1572-0241.2006.00627_6.x
– ident: p_39
  doi: 10.1515/CCLM.2007.290
– ident: p_16
  doi: 10.1515/CCLM.2004.121
– ident: p_23
  doi: 10.1515/CCLM.2005.095
– ident: p_34
  doi: 10.1309/W8J8-5AG4-WDG6-JGJ9
– ident: p_11
  doi: 10.1373/clinchem.2007.098228
– start-page: 2251
  year: 2006
  ident: p_18
  publication-title: Philadelphia, PA: Elsevier Saunders
– ident: p_25
  doi: 10.1002/hep.23200
– volume: 48
  start-page: 338
  year: 2002
  ident: p_19
  publication-title: Clin Chem
  doi: 10.1093/clinchem/48.11.1987
– volume: 137
  start-page: 1
  year: 2002
  ident: p_30
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-137-1-200207020-00006
– ident: p_14
  doi: 10.1080/00365510410006694
– ident: p_33
  doi: 10.1046/j.1423-0410.2003.00347.x
– ident: p_17
  doi: 10.3109/00365519509089619
– ident: p_27
  doi: 10.1046/j.1440-1746.2002.02881.x
– ident: p_29
  doi: 10.1016/S0009-8981(02)00341-8
– volume: 31
  start-page: 254
  year: 2007
  ident: p_21
  publication-title: Biochim Clin
– ident: p_32
  doi: 10.1136/jcp.2007.053637
– ident: p_37
  doi: 10.1016/j.ab.2007.10.025
– ident: p_10
  doi: 10.1373/clinchem.2007.091843
– ident: p_31
  doi: 10.1080/00365510410002742
– ident: p_22
  doi: 10.1001/archinternmed.2007.131
– ident: p_7
  doi: 10.1258/acb.2008.008170
– ident: p_9
  doi: 10.1515/CCLM.2004.133
– ident: p_28
  doi: 10.1023/A:1022809430756
– ident: p_20
  doi: 10.1373/clinchem.2003.027953
SSID ssj0015547
Score 2.2975829
Snippet Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of...
Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of...
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1593
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
alanine aminotransferase
Alanine Transaminase - blood
aspartate aminotransferase
Aspartate Aminotransferases - blood
Biological and medical sciences
Blood Chemical Analysis - standards
Ethnic Groups
Female
gamma-Glutamyltransferase - blood
General aspects
Humans
International Agencies
Investigative techniques, diagnostic techniques (general aspects)
Laboratories - standards
Male
Medical sciences
Middle Aged
reference intervals
Reference Values
Reproducibility of Results
Sex Factors
Young Adult
γ-glutamyl transferase
Title Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study
URI https://api.istex.fr/ark:/67375/QT4-P41PM128-D/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/21034260
https://www.proquest.com/docview/763471185
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGKgFvMAaUj8kPFDF1gaRx4pS3Les-0LoNkaKNl8hJHWmiS1GaIsbPgv_B7-GRe53ES7ZOCF6iqrlOotwT-9j33GtCXnBummOe9A3pedJgY5YYEWNjgyeAoAgI0tjBBOfhobs3Yu9OnJOlpd811dI8j17H3xfmlfyPV-E_8Ctmyf6DZ_VF4Q_4Df6FI3gYjtd9vHCo8avExrjauE1FA0rXYvy8GTwvW03xGbt6ixFVNCL7ipWUlagSehkM0cuuOD9Lp7nitjKD8Q756OaHoNPrK9XnRKRIUhdaHaCVepiOP-hs2SiOz8X5BWrbG5a7u8ryLO3CO5uruEEmZ_NJPityX6AD2t_x_UL6iFpSrD-ti-Ji-ATmokdBsK94uMwArHEhLlNwHRwentZCHdU67wgFe8GRPqNXmqBB99P-6ai-HILSksZyyDZ8W9n8opI2F506s5nhukUmdtXrM6-ObqvWhwPBs2t8wHKLy18baxxVlsP3D4aFQtAu8lKbNb2vjLVaAdmzgYf23f4t0urZ3HOWSWtzd2vwUUfAgOapjYGqZy_rw8JN3zRu2eBTLewavqG-V8wAe0mxN8vNkydFooJ7ZPUyvZQeazTfJ0syXSF3_ArBK-T2sATtA_KjwCrVWKUaqxSwSjVW6VUU0leA1PUNWqJ00fmDYJ0CQumvnxqdtGEB2FyHG1KFzLe0xCVFXEJDirikNVxShctVMtoZBP6eUe4zYsS2a-bweqVjJbEZma6A-UdkweuWLk-k6EW8J1nC-twRiSktx8OzrsuFJ6Mo8Tyg21LYD8lyOk3lY0JNS9o9ycU4ZpIBjxAsNhkXggsntmOWtMlG5a0wLovw414wkxAn4-DcEJ0bonNDcG6bvNTmX4rqMzcaKtdrK5F9Rskmd8L3AQuPmXU8BCYabrfJWgMbukEFyDahFVhC8DqGD0Uqp_NZCEwEmCzw-zZ5VIDosrGFlURd88nfrv6U3L38aJ-R5Tyby-fA6vNorfwA_gBhEvqS
linkProvider Walter de Gruyter
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Clinical+chemistry+and+laboratory+medicine&rft.atitle=Common+reference+intervals+for+aspartate+aminotransferase+%28AST%29%2C+alanine+aminotransferase+%28ALT%29+and+%CE%B3-glutamyl+transferase+%28GGT%29+in+serum%3A+results+from+an+IFCC+multicenter+study&rft.au=CERIOTTI%2C+Ferruccio&rft.au=HENNY%2C+Joseph&rft.au=QUERALTO%2C+Josep&rft.au=SHEN+ZIYU&rft.date=2010-11-01&rft.pub=De+Gruyter&rft.issn=1434-6621&rft.volume=48&rft.issue=11&rft.spage=1593&rft.epage=1601&rft_id=info:doi/10.1515%2FCCLM.2010.315&rft.externalDBID=n%2Fa&rft.externalDocID=23441969
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon